-
Sector Analysis
Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032
Non-Alcoholic Steatohepatitis (NASH) Report Overview In the 7MM, there were 22,036,613 diagnosed prevalent cases of NASH in 2022. The market is expected to grow at an AGR of more than 2% during 2022-2032. The Non-Alcoholic Steatohepatitis (NASH) market research report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for NASH in the seven major markets. The report also includes a 10-year epidemiology forecast for the diagnosed prevalence of NASH. NASH Market Outlook, 2022-2032 (Diagnosed...
-
Product Insights
Non-Alcoholic Steatohepatitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Market Report Overview The Non-Alcoholic Steatohepatitis (NASH) clinical trial market research report provides an overview of the NASH clinical trials scenario. The report provides top-line data relating to the clinical trials on NASH. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non Alcoholic Fatty Liver Pipeline Drugs Analysis Overview Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis when no other causes for secondary hepatic fat accumulation (such as excessive alcohol consumption) can be identified. NAFLD ranges from the more benign condition of non-alcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), which is at the more severe end of the spectrum. The NAFLD marketed and pipeline drugs market research report provides a data-driven overview of the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.